Release issued 21st April 2000

Cambridge Healthtech Institute (CHI), a premier information resource to the biotechnical, pharmaceutical, and academic industries, is pleased to announce their BEYOND GENOME 2000 event. These three meetings will take place June 19-23, 2000 at The Fairmont Hotel and Hotel Niko in San Francisco, California.

Beyond Genome 2000 is a five-day event covering a number of computational tools used in the analysis and correlation of genomic data. The first two days are dedicated to Bioinformatics and Genome Research, focusing on the computational advances necessary to comprehend the vast amount of information gathered through the Human Genome Project. Next is a two-day conference on In Silico Biology that explores tools being developed to translate raw data into workable models that will provide guidance for target selection. The final portion of Beyond Genome concentrates on Proteomics, which will provide in-depth coverage of recent developments in the field of high- throughput protein expression analysis and its impact on diagnostic and therapeutic product development.

Last year over 700 people attended the event and 20 companies have already signed up to exhibit this year. Researchers and executives interested in discovering how these computational methods will help them make sense of genomic data should not miss CHI's Beyond Genome 2000.

For more detailed information, please contact Jennifer Laakso, Marketing Coordinator, Cambridge Healthtech Institute, (617) 630-1385, e-mail: jlaakso@healthtech.com

http://www.healthtech.com/conference/00bin

(11th January 2002) CHI's Genome Tri-Conference 2002…The Molecular Medicine Marketplace

(16th March 2001) CHI announces HUMAN PROTEOME PROJECT conference

(30th January 2001) CHI Announces GENOME TRI-CONFERENCE 2001

(2nd May 2000) CAMBRIDGE HEALTHTECH INSTITUTE Announces 7th Annual HIGH-THROUGHPUT TECHNOLOGIES 2000: Summit & Exposition

(3rd March 2000) CAMBRIDGE HEALTHTECH INSTITUTE Announces 2nd Annual PROTEIN DISCOVERY TECHNOLOGIES: New Methods and Applications in Therapeutic Development Conference